NCT05928624

A Pilot Trial to Test the Feasibility of Utilizing Home Blood Pressure Monitoring to Optimize the Administration of Midodrine Among Decompensated Cirrhosis Patients

Wireless Automated Tracking in Cirrhosis Patients at Home (WATCH) Trial: A Randomized Single Blind Trial Testing the Use of Home Monitoring Among Decompensated Cirrhosis Patients

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 69 (actual)
• Sponsor: University of California, San Francisco · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a randomized single-blind feasibility trial to test the utilization of home blood pressure devices to improve the clinical management of decompensated cirrhosis patients.

Detailed description

This is a feasibility trial to determine the feasibility of using home monitoring devices (e.g. blood pressure cuffs) to improve outcomes for cirrhosis patients.

Conditions

• Cirrhosis, Liver
• Portal Hypertension
• Ascites Hepatic

Interventions

Type	Name	Description
DEVICE	Withings Home Blood Pressure Device and Scale	The intervention will be whether the data generated from home monitoring devices are shared with the clinical providers. The investigators are not testing the efficacy of these approved devices.
OTHER	Standard of Care	Standard of Care

Timeline

• Start date: 2023-09-22
• Primary completion: 2024-07-01
• Completion: 2024-07-01
• First posted: 2023-07-03
• Last updated: 2025-07-22
• Results posted: 2025-07-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study